Blood transfusion

Article Abstract:

The US blood supply is now so safe that the decision to transfuse blood will be determined by cost considerations and whether the patient needs a blood transfusion. The number of units of blood transfused in the US rose from 10 million in 1980 to 12.2 million in 1986, and then dropped to 11.4 million in 1997. Part of the drop resulted from the fear of contagious diseases transmitted through blood products, including HIV, hepatitis B and hepatitis C. Blood transfusion can cause other adverse reactions. Some patients may be getting blood unnecessarily whereas others are not getting the blood they need.

Analysis, Blood transfusion

---

Erythropoietin therapy

Article Abstract:

Erythropoietin could be given to some surgical patients to eliminate the need for blood transfusions. Erythropoietin is a naturally produced hormone that stimulates blood cell production. Patients with pre-operative anemia or those who will lose 1 to 3 liters of blood during surgery may benefit from pre-operative erythropoietin. Pre-operative erythropoietin could also be combined with autologous blood donations, in which patients donate blood that will be given back to them after surgery. Erythropoietin can be effective even in patients who do not donate autologous blood.

Health aspects, Usage, Complications and side effects, Surgery, Postoperative complications, Erythropoietin, Recombinant, Recombinant erythropoietin, Blood transfusion, Autologous, Autologous blood transfusion

---

Anemia of chronic disease

Article Abstract:

Anemia of chronic disease, the anemia that is the second most prevalent after anemia caused by iron deficiency, occurs in patients with acute or chronic immune activation. The most frequent conditions associated with anemia of chronic disease are listed.

United Kingdom, Causes of, Risk factors, Chronic diseases, Iron deficiency anemia

Similar abstracts:

• Abstracts: Goodbye to bio-baby. Workout injuries: preventing the pain. What happens to your body when...?
• Abstracts: Bone density changes in women who receive thromboprophylaxis in pregnancy. Thromboprophylaxis and pregnancy: Two randomized controlled pilot trails that used low-molecular-weight heparin
• Abstracts: Clinical and ultrasonographic features of dextroposition of the fetal heart. Use of the mitral valve-tricuspid valve distance as a marker of fetal endocardial cushion defects
• Abstracts: Nysatin. Emollient cream. Topical fusidic acid
• Abstracts: Professional development: anaemia. Ensuring appropriate use of blood transfusion in anaemia. The benefits of understanding the pathophysiology of anaemia

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.